⌘K

Login Start Free

Home/Filings/4/0001662579-23-000102

4//SEC Filing

Hirsch Andrew 4

Accession 0001662579-23-000102

CIK 0001662579other

View on SEC.gov Company Profile

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 7:24 PM ET

Size

5.3 KB

Accession

0001662579-23-000102

Insider Transaction Report

Form 4

Period: 2023-09-18

C4 Therapeutics, Inc.CCCC

DirectorPresident & CEO

Transactions

Award
Stock Option (Right to Buy)
2023-09-18+489,600→ 489,600 total
Exercise: $2.15Exp: 2033-09-17→ Common Stock (489,600 underlying)

Footnotes (1)

[F1]This option shall vest in full on September 18, 2025, subject to the Reporting Person's continued service on such date.

Documents

1 file

4
wk-form4_1695165874.xmlPrimary
FORM 4

Issuer

C4 Therapeutics, Inc.

CIK 0001662579

Entity typeother

Related Parties

1

filerCIK 0001586707

Filing Metadata

Form type: 4
Filed: Sep 18, 8:00 PM ET
Accepted: Sep 19, 7:24 PM ET
Size: 5.3 KB

View on SEC.gov